People · Operator
Named in public records as an officer, director or promoter · active 2020–2021 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Rgenta Therapeutics, Inc. | — | Pharma | Series A | $18.9M | $150.2M | 2020 |
Zhiping Simon Weng at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Zhiping Simon Weng on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Judith Simon Li | 1 | 1 |
| Sun Simon Linghao | 1 | 1 |
| Hualin Simon Xi | 1 | 1 |
| Fei Simon Shen | 1 | 1 |
| Debasish Simon Roychowdhury | 1 | 1 |
| Hongbo Simon Lu | 1 | 1 |
| Travis Simon Wager | 1 | 1 |
| Martin Simon Heidecker | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.